Extended Inflammation Parameters (EIP) as Markers of Immune System Cell Activation in Psoriasis
Table 2
Descriptive characteristics of parameters belonging to the EIP group in the study groups and the control group.
Tested parameter
Group
N
Average
Median
Min
Max
SD
1.
NEUT-RI (FI)
Control group
30
44.01
43.50
40.30
50.10
2.10
A group of patients with plaque psoriasis
25
51.28
51.70
41.80
59.70
5.45
A group of patients with psoriatic arthritis
6
46.80
45.90
39.20
54.80
5.96
2.
NEUT-GI (SI)
Control group
30
146.68
146.20
137.80
157.00
4.25
A group of patients with plaque psoriasis
25
151.44
152.10
144.20
158.40
3.52
A group of patients with psoriatic arthritis
6
150.42
149.85
142.10
159.70
6.21
3.
RE-LYMPH (103/μl)
Control group
30
0.04
0.03
0.01
0.08
0.02
A group of patients with plaque psoriasis
25
0.29
0.28
0.05
0.98
0.22
A group of patients with psoriatic arthritis
6
0.15
0.15
0.04
0.34
0.12
4.
AS-LYMPH (103/μl)
Control group
30
0.00
0.00
0.00
0.00
0.00
A group of patients with plaque psoriasis
25
0.00
0.00
0.00
0.00
0.00
A group of patients with psoriatic arthritis
6
0.001
0.00
0.00
0.04
0.02
N: the number of all variables; SD: standard deviation; NEUT-GI: neutrophil granularity intensity; NEUT-RI: neutrophil reactive intensity; RE-LYMPH: reactive lymphocytes; AS-LYMPH: antibody-secreting reactive lymphocytes.
